{
     "PMID": "20847422",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20110829",
     "LR": "20170220",
     "IS": "1875-8908 (Electronic) 1387-2877 (Linking)",
     "VI": "22",
     "IP": "1",
     "DP": "2010",
     "TI": "Importance of the caspase cleavage site in amyloid-beta protein precursor.",
     "PG": "57-63",
     "LID": "10.3233/JAD-2010-100537 [doi]",
     "AB": "Reports from multiple laboratories have now been published analyzing the critical nature of the caspase cleavage site of amyloid-beta protein precursor (AbetaPP) for cell death induction, synaptic loss, hippocampal atrophy, long-term potentiation, memory loss, neophobia, and other aspects of the Alzheimer's phenotype. Here we review the results and implications of these studies for the understanding of Alzheimer's disease pathophysiology and the potential development of therapeutics that target this site in AbetaPP.",
     "FAU": [
          "Bredesen, Dale E",
          "John, Varghese",
          "Galvan, Veronica"
     ],
     "AU": [
          "Bredesen DE",
          "John V",
          "Galvan V"
     ],
     "AD": "Buck Institute for Age Research, Novato, CA 94945, USA. dbredesen@buckinstitute.org",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 AG034427/AG/NIA NIH HHS/United States",
          "AG034427/AG/NIA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't",
          "Review"
     ],
     "PL": "Netherlands",
     "TA": "J Alzheimers Dis",
     "JT": "Journal of Alzheimer's disease : JAD",
     "JID": "9814863",
     "RN": [
          "0 (Amyloid beta-Protein Precursor)",
          "EC 3.4.22.- (Caspases)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/drug therapy/*enzymology/*pathology",
          "Amyloid beta-Protein Precursor/chemistry/*metabolism",
          "Animals",
          "Atrophy",
          "Caspases/chemistry/*metabolism",
          "Cell Death/genetics",
          "Drug Delivery Systems",
          "Hippocampus/enzymology/*pathology/physiopathology",
          "Humans",
          "Long-Term Potentiation/genetics",
          "Memory Disorders/drug therapy/metabolism/pathology",
          "Synapses/genetics/pathology"
     ],
     "PMC": "PMC3968071",
     "MID": [
          "NIHMS564918"
     ],
     "EDAT": "2010/09/18 06:00",
     "MHDA": "2011/08/30 06:00",
     "CRDT": [
          "2010/09/18 06:00"
     ],
     "PHST": [
          "2010/09/18 06:00 [entrez]",
          "2010/09/18 06:00 [pubmed]",
          "2011/08/30 06:00 [medline]"
     ],
     "AID": [
          "68634076X6856J11 [pii]",
          "10.3233/JAD-2010-100537 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Alzheimers Dis. 2010;22(1):57-63. doi: 10.3233/JAD-2010-100537.",
     "term": "hippocampus"
}